Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.
- Citation:
- J Clin Oncol vol 21 (6) 976-83
- Year:
- 2003
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA31946
- Corr. Author:
- Authors:
- I Craig Henderson Donald A Berry George D Demetri Constance T Cirrincione Lori J Goldstein Silvana Martino James N Ingle M Robert Cooper Daniel F Hayes Katherine H Tkaczuk Gini Fleming James F Holland David B Duggan John T Carpenter Emil Frei Richard L Schilsky William C Wood Hyman B Muss Larry Norton
- Networks:
- Study
- CALGB-9344
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Antibiotics, Antineoplastic, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Disease-Free Survival, Dose-Response Relationship, Drug, Doxorubicin, Female, Humans, Lymphatic Metastasis, Middle Aged, Paclitaxel, Proportional Hazards Models, Treatment Outcome